Lv3
330 积分 2023-07-26 加入
Multisection CT Protocols: Sex- and Age-specific Conversion Factors Used to Determine Effective Dose from Dose-Length Product
15天前
已完结
Synergistic Combinations for Improved Therapeutic Outcomes in Triple Negative Breast Cancer
20天前
已完结
Impact of immune checkpoint inhibition on ovarian reserve in patients with melanoma enrolled in the ECOG-ACRIN E1609 adjuvant trial
4个月前
已完结
Effects of Gonadotropin-Releasing Hormone Analogs on Ovarian Function Against Chemotherapy-Induced Gonadotoxic Effects in Premenopausal Women With Breast Cancer in China
4个月前
已完结
Utility of gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage in premenopausal women with breast cancer: a systematic review and meta-analysis
4个月前
已完结
Sitravatinib plus tislelizumab in locally recurrent or metastatic triple-negative breast cancer: a multi-cohort, single-arm, phase II clinical trial (SPARK Trial)
4个月前
已完结
The evolving landscape of metastatic HER2-positive, hormone receptor-positive Breast Cancer
5个月前
已完结
Gestion des effets secondaires de l’hormonothérapie du cancer du sein chez la femme jeune
6个月前
已关闭
Molecular mechanisms and clinical management of cancer bone metastasis
7个月前
已完结
PROTAC SERD vepdegestrant outperforms fulvestrant for advanced-stage ER+HER2− breast cancer harbouring acquired ESR1 mutations
8个月前
已完结
皖公网安备34019202002308
